Back
Gap Vs. Novo Nordisk AS Industry Stock Comparison
Buy
53
GAP
Gap
Last Price:
$24.05
Seasonality Move:
9.88%
Sell
18
NONOF
Novo Nordisk AS
Last Price:
$87.53
Seasonality Move:
6.72%
Sell
18
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.86. The Score for NONOF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
GAP Stock Price Chart
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.86Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
GAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 49.89 | Sell |
Chaikin Money Flow: | -993620 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.78 - 25.74) | Sell |
Bollinger Bands (100): | (20.67 - 24.03) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.61 | Sell |
Relative Strength Index (14 RSI): | 29.63 | Sell |
Chaikin Money Flow: | -16178 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.97 - 111.89) | Sell |
Bollinger Bands (100): | (106.42 - 130.98) | Sell |
GAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.25 | Sell |
20-day SMA: | 24.83 | Sell |
50-day SMA: | 23 | Buy |
200-day SMA: | 22.91 | Buy |
8-day EMA: | 24.3 | Sell |
20-day EMA: | 24.25 | Sell |
50-day EMA: | 23.4 | Buy |
200-day EMA: | 21.85 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102.02 | Sell |
20-day SMA: | 106 | Sell |
50-day SMA: | 108.66 | Sell |
200-day SMA: | 125.92 | Sell |
8-day EMA: | 98.92 | Sell |
20-day EMA: | 103.95 | Sell |
50-day EMA: | 109.19 | Sell |
200-day EMA: | 117.71 | Sell |
Gap Earnings Growth & GAP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.32 per share, an increase this year of $1.31 per share, and an increase next year of $0.81 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Gap Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |